Published in Telemedicine Business Week, May 30th, 2007
This trend article about Medical University of Vienna, Austria, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Investigators publish new data in the report "A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11." According to recent research from Vienna, Austria, "Peptides of the papillomavirus L2 minor capsid protein can induce antibodies (Ab) that neutralize a broad range of human papillomavirus (HPV) genotypes. Unfortunately, L2 is antigenically subdominant to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week